相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cortical spreading depression as a site of origin for migraine: Role of CGRP
Liesl N. Close et al.
CEPHALALGIA (2019)
Migraine treatment: the doors for the future are open, but with caution and prudence
Abouch V. Krymchantowski et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2019)
A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody
William Kielbasa et al.
CEPHALALGIA (2019)
Imaging of neuroinflammation in migraine with aura A [11C] PBR28 PET/MRI study
Daniel S. Albrecht et al.
NEUROLOGY (2019)
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Peter J. Goadsby et al.
CEPHALALGIA (2019)
Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets
Kristian Agmund Haanes et al.
CNS DRUGS (2019)
Fremanezumab as a preventive treatment for episodic and chronic migraine
Marcelo E. Bigal et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
CGRP and the Trigeminal System in Migraine
Smriti Iyengar et al.
HEADACHE (2019)
Erenumab in chronic migraine Patient-reported outcomes in a randomized double-blind study
Richard B. Lipton et al.
NEUROLOGY (2019)
Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis
Giuseppe Tringali et al.
PEPTIDES (2019)
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
David W. Dodick
CEPHALALGIA (2019)
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Simona Sacco et al.
JOURNAL OF HEADACHE AND PAIN (2019)
TRP Channels and Migraine: Recent Developments and New Therapeutic Opportunities
Silvia Benemei et al.
PHARMACEUTICALS (2019)
CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study
Clara Dominguez et al.
HEADACHE (2018)
Activation of pial and dural macrophages and dendritic cells by cortical spreading depression
Aaron J. Schain et al.
ANNALS OF NEUROLOGY (2018)
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
Vladimir Skljarevski et al.
CEPHALALGIA (2018)
A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects
Orit Cohen-Barak et al.
CEPHALALGIA (2018)
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
David W. Dodick et al.
CEPHALALGIA (2018)
Emerging Treatments in Episodic Migraine
Kate W. Grimsrud et al.
CURRENT PAIN AND HEADACHE REPORTS (2018)
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine A Randomized Clinical Trial
David W. Dodick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The pathophysiology of migraine: implications for clinical management
Andrew Charles
LANCET NEUROLOGY (2018)
Neurogenic inflammation and its role in migraine
Roshni Ramachandran
SEMINARS IN IMMUNOPATHOLOGY (2018)
New preventive treatments for migraine High prices put promising monoclonal antibodies out of reach for many patients
Rebecca Burch et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Engineering of Botulinum Neurotoxins for Biomedical Applications
Robert P. Webb
TOXINS (2018)
New preventive treatments for migraine High prices put promising monoclonal antibodies out of reach for many patients
Rebecca Burch et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Evaluation of Galcanezumab for the Prevention of Episodic Migraine The EVOLVE-1 Randomized Clinical Trial
Virginia L. Stauffer et al.
JAMA NEUROLOGY (2018)
Migraine in Systemic Autoimmune Diseases
Cinzia Cavestro et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2018)
PACAP38 and PAC1 receptor blockade: a new target for headache?
Eloisa Rubio-Beltran et al.
JOURNAL OF HEADACHE AND PAIN (2018)
The efficacy and safety of calcitonin gene-related peptide monoclonal antibody for episodic migraine: a meta-analysis
Yuhan Zhu et al.
NEUROLOGICAL SCIENCES (2018)
Galcanezumab in chronic migraine The randomized, double-blind, placebo-controlled REGAIN study
Holland C. Detke et al.
NEUROLOGY (2018)
Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways
Zachary F. Gerring et al.
CEPHALALGIA (2018)
The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine
Lars Edvinsson
HEADACHE (2017)
Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody
Agustin Melo-Carrillo et al.
JOURNAL OF NEUROSCIENCE (2017)
Cortical Spreading Depression Closes Paravascular Space and Impairs Glymphatic Flow: Implications for Migraine Headache
Aaron J. Schain et al.
JOURNAL OF NEUROSCIENCE (2017)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
INVOLVEMENT OF SUBSTANCE P IN THE ANTINOCICEPTIVE EFFECT OF BOTULINUM TOXIN TYPE A: EVIDENCE FROM KNOCKOUT MICE
Ivica Matak et al.
NEUROSCIENCE (2017)
Mast cells in neuroinflammation and brain disorders
Erik Hendriksen et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Fremanezumab for the Preventive Treatment of Chronic Migraine
Stephen D. Silberstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
Marco Pirazzini et al.
PHARMACOLOGICAL REVIEWS (2017)
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Amy R. Tso et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2017)
Calcitonin gene-related peptide monoclonal antibody for preventive treatment of episodic migraine: A meta analysis
Peiwei Hong et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2017)
Change in brain network connectivity during PACAP38-induced migraine attacks A resting-state functional MRI study
Faisal Mohammad Amin et al.
NEUROLOGY (2016)
Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
XiChun Zhang et al.
CEPHALALGIA (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
Evidence for brain glial activation in chronic pain patients
Marco L. Loggia et al.
BRAIN (2015)
Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture study
Jacob Edvinsson et al.
JOURNAL OF HEADACHE AND PAIN (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
The Glymphatic System: A Beginner's Guide
Nadia Aalling Jessen et al.
NEUROCHEMICAL RESEARCH (2015)
Migraine and neuropeptides
Janos Tajti et al.
NEUROPEPTIDES (2015)
OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
Eva Cernuda-Morollon et al.
PAIN (2015)
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
Faisal Mohammad Amin et al.
BRAIN (2014)
Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains
Rami Burstein et al.
CEPHALALGIA (2014)
PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: Possible involvement of mast cells
Deepak K. Bhatt et al.
CEPHALALGIA (2014)
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
Innervation of Rat and Human Dura Mater and Pericranial Tissues in the Parieto-Temporal Region by Meningeal Afferents
Markus Schueler et al.
HEADACHE (2014)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Pearls and pitfalls in experimental in vivo models of migraine: Dural trigeminovascular nociception
Simon Akerman et al.
CEPHALALGIA (2013)
Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
Sajedeh Eftekhari et al.
JOURNAL OF PAIN (2013)
Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain
Rodrigo Noseda et al.
PAIN (2013)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
Anthony J. Harmar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers
Faisal Mohammad Amin et al.
CEPHALALGIA (2012)
Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38
Michael Baun et al.
CEPHALALGIA (2012)
Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine
Caterina Mainero et al.
ANNALS OF NEUROLOGY (2011)
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program
Sheena K. Aurora et al.
HEADACHE (2011)
Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
Andrew Blumenfeld et al.
HEADACHE (2010)
Properties of a general PK/PD model of antibody-ligand interactions for therapeutic antibodies that bind to soluble endogenous targets
Jasmine P. Davda et al.
MABS (2010)
CGRP and its receptors provide new insights into migraine pathophysiology
Tony W. Ho et al.
NATURE REVIEWS NEUROLOGY (2010)
DIFFERENTIAL DISTRIBUTION OF CALCITONIN GENE-RELATED PEPTIDE AND ITS RECEPTOR COMPONENTS IN THE HUMAN TRIGEMINAL GANGLION
S. Eftekhari et al.
NEUROSCIENCE (2010)
Origin of pain in migraine: evidence for peripheral sensitisation
Jes Olesen et al.
LANCET NEUROLOGY (2009)
Do the unintended actions of botulinum toxin at distant sites have clinical implications?
Antonio Curra et al.
NEUROLOGY (2009)
VPAC and PAC receptors: From ligands to function
Louise Dickson et al.
PHARMACOLOGY & THERAPEUTICS (2009)
CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
J. Zeller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Modulation of meningeal nociceptors mechanosensitivity by peripheral proteinase-activated receptor-2: the role of mast cells
X-C Zhang et al.
CEPHALALGIA (2008)
Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators
Xi-Chun Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Mast cell degranulation activates a pain pathway underlying migraine headache
Dan Levy et al.
PAIN (2007)
Action of botulinum neurotoxins in the central nervous system: Antiepileptic effects
Yuri Bozzi et al.
NEUROTOXICITY RESEARCH (2006)
Response properties of dural nociceptors in relation to headache
AM Strassman et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally
P Sarchielli et al.
HEADACHE (2006)
Plasma cytokine levels in migraineurs and controls
F Perini et al.
HEADACHE (2005)
Neurobiology in primary headaches
L Edvinsson et al.
BRAIN RESEARCH REVIEWS (2005)
Axon diameters and intradural trajectories of the dural innervation in the rat
AM Strassman et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura
D Levy et al.
JOURNAL OF NEUROPHYSIOLOGY (2002)
Substance P and calcitonin gene-related peptide increase IL-1β, IL-6 and TNFα secretion from human peripheral blood mononuclear cells
MC Cuesta et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Delayed inflammation in rat meninges: implications for migraine pathophysiology
U Reuter et al.
BRAIN (2001)
Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats
QP Ma et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999
RHA Kemper et al.
CEPHALALGIA (2001)
Neurogenic inflammation in the context of migraine
DJ Williamson et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2001)
Catecholaminergic and acetylcholine esterase containing nerves of cranial and spinal dura mater in humans and rodents
M Artico et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2001)
Brainstem activation specific to migraine headache
A Bahra et al.
LANCET (2001)
Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks
P Sarchielli et al.
CEPHALALGIA (2000)
The role of adhesion molecules in migraine: a debate
P Martelletti et al.
CEPHALALGIA (2000)
分享论文
